key: cord-0717326-4rzqgz9t
authors: Ciccarese, Giulia; Parodi, Aurora; Drago, Francesco
title: SARS‐COV‐2 As Possible Inducer of Viral Reactivations
date: 2020-06-19
journal: Dermatol Ther
DOI: 10.1111/dth.13878
sha: 1fc2ed585bb4a12962c844148b5068d1e0f39ec4
doc_id: 717326
cord_uid: 4rzqgz9t

nan

. In addition, in PR there is also evidence that HHV-7 operates as a primer providing the reactivation of latent HHV-6; once reactivated, latent HHV-6 genomes may predominate, leading HHV-7 to disappear or preventing its detection by PCR or serology 6 .

This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7

Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin

This article is protected by copyright. All rights reserved

Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6

Pityriasis Rosea: A Comprehensive Classification

In vitro activation of human herpesviruses 6 and 7 from latency

Viral reactivation and skin eruptions

Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases